Skip to Main Content
It looks like you're using Internet Explorer 11 or older. This website works best with modern browsers such as the latest versions of Chrome, Firefox, Safari, and Edge. If you continue with this browser, you may see unexpected results.

COVID-19 Feature Articles: Issue 89 January 20

A guide that lists selected articles regarding COVID-19 relevant to SVHA

COVID-19 Feature Articles

This page lists feature articles on COVID-19 relevant to people working at St Vincent's Health Australia.

All articles listed are open access unless stated otherwise.

Therapy

COVID-19 therapeutics for nonhospitalized patients.
JAMA:2022: January 14 Full text

Effect of subcutaneous casirivimab and imdevimab antibody combination vs placebo on development of symptomatic COVID-19 in early asymptomatic SARS-CoV-2 infection: a randomized clinical trial.
JAMA:2022: January 14 
Full text

Usefulness of combined renin-angiotensin system inhibitors and diuretic treatment in patients hospitalized with COVID-19.
American Journal of Cardiology:2022: January 10 Full text

Clinical Practice

Perioperative cardiovascular considerations prior to elective noncardiac surgery in patients with a history of COVID-19.
JAMA Surgery:2022: January 10 Full text

Assessment of functional mobility after COVID-19 in adults aged 50 years or older in the Canadian Longitudinal Study on Aging.
JAMA Network Open:2022: January 12 Full text

Clinical profile and recovery pattern of dysphagia in the COVID-19 patient: a prospective observational cohort within NSW. AUS
Australian Critical Care:2022: January 14 Full text

Evaluating immunity to SARS-CoV-2 in nursing home residents using saliva IgG.
Journal of the American Geriatrics Society:2022: January 17 Full text

Pathophysiology

Risk for newly diagnosed diabetes >30 days after SARS-CoV-2 infection among persons aged <18 years — United States, March 1, 2020–June 28, 2021.
Morbidity and Mortality Weekly Report (MMWR):2022: January 7 Full text

SARS-CoV-2 adipose tissue infection and hyperglycemia: a further step towards the understanding of severe COVID-19.
Metabolism Open:2022: January 13 Full text

Long Covid

Mild respiratory SARS-CoV-2 infection can cause multi-lineage cellular dysregulation and myelin loss in the brain.
bioRxiv:2022: January 10 Full text

Immunological dysfunction persists for 8 months following initial mild-to-moderate SARS-CoV-2 infection.
Nature Immunology:2022: January 13 Full text

Infection Control

Practical indicators for risk of airborne transmission in shared indoor environments and their application to COVID-19 outbreaks.
Environmental Science and Technology:2022: January 5 Full text

Surgical helmets can be converted into efficient disinfectable powered air-purifying respirators.
American Journal of Infection Control:2021: December 25 Full text

Vaccines

Association of a third dose of BNT162b2 vaccine with incidence of SARS-CoV-2 infection among health care workers in Israel.
JAMA:2022: January 10 Full text

Association between vaccination status and reported incidence of post-acute COVID-19 symptoms in Israel: a cross-sectional study of patients tested between March 2020 and November 2021.
medRxiv:2022: January 17 Full text

Immunology

Ancestral SARS-CoV-2-specific T cells cross-recognize Omicron.
Nature Medicine:2022: January 14 Full text

Resilient T cell responses to B.1.1.529 (Omicron) SARS-CoV-2 variant.
medRxiv:2022: January 16 Full text

Chief Librarian - St Vincent's Hospital, Melbourne

Profile Photo
Jeremy Taylor
Contact:
03 9231 2542